Applied BioCode Corporation (6598) Stock Overview

Applied BioCode Corporation designs, develops, and commercializes multiplex diagnostic testing products in California. The company's products include the BioCode MDx 3000 system, an automated molecular diagnostic system that automates the PCR amplification, hybridization, and detection steps of molecular testing; and the BioCode 2500 analyzer, a system that reads barcoded magnetic beads (BMB) and displays the barcode and fluorescence intensity for each BMB. It develops assays, such as BioCode SARS-CoV-2 Assay, a nucleic acid assay for the detection of SARS-CoV-2 nucleic acid in nasopharyngeal swabs; and CoV-2 Flu Assay for detection of RNA and various Influenza, as well as offers gastrointestinal and respiratory pathogen panel related products. In addition, the company provides general purpose reagents and manufactures 28 fungal analyte specific reagents. Further, it offers barcoded bead related accessories. Applied BioCode Corporation is based in Santa Fe Springs, California.